Palonosetron, Aprepitant, and Low-Dose Dexamethasone in Preventing Nausea and Vomiting in Patients Undergoing High-Dose Chemotherapy and Stem Cell Transplant for Multiple Myeloma or Lymphoma - Related Studies

Palonosetron, Aprepitant, and Low-Dose Dexamethasone in Preventing Nausea and Vomiting in Patients Undergoing High-Dose Chemotherapy and Stem Cell Transplant for Multiple Myeloma or Lymphoma

This study is currently recruiting participants.

Study NCT00631930. Last updated on November 13, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Lymphoma
		Nausea and Vomiting

2	Additional conditions recognized in this trial
		Lymphoma, Large-Cell, Immunoblastic
		Lymphoma, Non-Hodgkin
		Multiple Myeloma
		Nausea
		Neoplasms, Plasma Cell
		Vomiting

3	More general conditions related to this trial
		Blood Protein Disorders
		Cardiovascular Diseases
		Hematologic Diseases
		Hemorrhagic Disorders
		Hemostatic Disorders
		Immune System Diseases
		Immunoproliferative Disorders
		Lymphatic Diseases
		Lymphoproliferative Disorders
		Neoplasms
		Neoplasms by Histologic Type
		Paraproteinemias
		Signs and Symptoms
		Signs and Symptoms, Digestive
		Vascular Diseases

4	Interventions listed in this trial
		aprepitant
		carmustine
		cyclophosphamide
		cytarabine
		dexamethasone
		etoposide
		melphalan
		palonosetron hydrochloride

5	Additional drug interventions recognized in this trial
		Dexamethasone acetate
		Palonosetron

6	More general drug interventions related to this trial
		Alkylating Agents
		Anti-Infective Agents
		Anti-Inflammatory Agents
		Antiemetics
		Antimetabolites
		Antimetabolites, Antineoplastic
		Antineoplastic Agents
		Antineoplastic Agents, Alkylating
		Antineoplastic Agents, Hormonal
		Antirheumatic Agents
		Antiviral Agents
		Autonomic Agents
		Central Nervous System Agents
		Gastrointestinal Agents
		Glucocorticoids
		Hormones
		Hormones, Hormone Substitutes, and Hormone Antagonists
		Immunologic Factors
		Immunosuppressive Agents
		Molecular Mechanisms of Pharmacological Action
		Myeloablative Agonists
		Neurotransmitter Agents
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Serotonin Agents
		Serotonin Antagonists
		Therapeutic Uses

7	Sponsors listed in this trial
		University of Kansas